A randomised comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR (RADial access for CARotid artery stenting) study

Abstract

The transradial approach for carotid artery stenting is safe and efficacious; however, the crossover rate is higher with transradial access. There are no differences in the total procedure duration and fluoroscopy time between the two approaches but the radiation dose is significantly higher in the radial group, and the hospitalisation is shorter with the use of transradial access by per-protocol analysis. By evaluating the patient data according to intention-to-treat analysis we found no difference in major adverse events and hospitalisation. In both groups, vascular complications rarely occurred.

Transcervical access, reversal of flow and mesh-covered stents: New options in the armamentarium of carotid artery stenting

“…It was concluded that both approaches are safe and efficacious. These results verified the results of an earlier study[33]. …”

Effectiveness of a handmade “New Carotid Catheter” in transradial carotid angiography: A comparison with conventional multipurpose catheters

“…Although we have only discussed carotid imaging in this publication, there have been successful studies on transradial carotid stenting. In fact, “the nitinol carotid stent” with “5F cylinder sheet” can be successfully applied transradial route …”

Safety and Feasibility of Transradial Access for Visceral Interventions in Patients with Thrombocytopenia

“…Although none of the procedures included in our study resulted in neurological complications, the relationship between TRA in peripheral interventions and cerebral emboli formation remains unresolved. While TRA-PCI has been shown to have fluoroscopy times equivalent to TFA-PCI [30], our study does not measure procedure and fluoroscopy times compared to TFA interventions required to achieve our 97.6 % rate of technical success. Similarly, the lack of a comparable TFA cohort limits our ability to ascertain relative benefits across access sites.…”